Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Speciality: Oncology
Description:
Welcome to our podcast, where we explore advances in hematology. Today, we discuss assessing the risk of therapy-related myeloid neoplasms, or t-MNs, by integrating clonal hematopoiesis with treatment exposure. Clonal hematopoiesis refers to the presence of genetic mutations in blood-forming cells, which can increase the risk of developing blood cancers. When patients undergo chemotherapy or radiation, these treatments can further elevate that risk. Recent research suggests that by analyzing both a patient’s clonal hematopoiesis profile and the types and doses of therapies they receive, clinicians can more accurately predict who is at higher risk for t-MNs. This integrated approach could lead to more personalized cancer care and better long-term outcomes.
See More Webinars @ Hidoc Webinars
1.
Higher levels of HIF2α found to slow down aggressive childhood cancer
2.
More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.
3.
Medicaid expansion tied to smaller declines in early-stage cancer detection
4.
Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care
5.
In women with extremely dense breasts, elevated MRI enhancement can help identify cancer risk.
1.
Deep Learning Fluorescence Imaging for Oral Cancer Surgery: In Silico Depth Quantification
2.
Targeted Therapies for Breast Cancer: What’s New?
3.
Plasma Proteoforms Reflecting Hematopoietic Stress
4.
Targeted Protein Degraders for Previously Undruggable Oncogenic Proteins
5.
Spatial Tumor Mapping for Individualized Cancer Therapy
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Comprehensive Update on Hematology
2.
Assessing Therapy-Related Myeloid Neoplasm Risk Through Clonal Hematopoiesis and Treatment Exposure Integration
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
4.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
5.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge